Consumers win as Supreme Court rules against FDA preemption

by Michael J. Evans on March 4, 2009

in Consumer Protection,Dangerous Products,Mass Torts and the Internet

The U.S. Supreme Court has ruled 6-3 that FDA approval of a prescription drug label does not preempt state tort claims by persons injured by the drug, according to Bloomberg and other sources. “Congress did not intend FDA oversight to be the exclusive means of ensuring drug safety and effectiveness,” Justice John Paul Stevens wrote for the court. The ruling affirmed a $7 million award to a musician who lost her arm after being injected with Wyeth’s Phenergan nausea treatment.

This settles an issue which has hung over consumers and the plaintiffs’ bar for several years. The Bush administration had agressively pushed for FDA preemption, as well as preemption in a number of other areas.

  • Share/Bookmark

Comments on this entry are closed.

Previous post:

Next post: